Evolution in hemophilia treatment

Authors

  • Rungrote Natesirinilkul Department of Pediatric Faculty of Medicine, Chiang Mai University

Keywords:

Hemophilia, cryoprecipitate, factor concentrate, desmopressin, gene therapy, treatment, ฮีโมฟีเลีย, ไครโอพริซิปิเตท, แฟคเตอร์เข้มข้น, ยา desmopressin, การรักษาด้วยยีน, การรักษา

Abstract

Objective Even though hemophilia has been known since the ancient time, the understanding of disease and proper management of hemophilia have just been established for 50 years. After the discovery of cryoprecipitate, which was a big step of hemophilia therapy, between 1950-1960, the therapy of hemophilia has been advancing progressively, including the usage of factor concentrate and desmopressin for on-demand and prophylactic treatment, the development of bypassing agent for hemophiliac patients with inhibitor, the production of long-acting factor concentrate and gene therapy in hemophiliac patients. This knowledge of hemophilia treatment is interesting and worth following in the future.

Downloads

Published

2024-04-19

How to Cite

1.
Natesirinilkul R. Evolution in hemophilia treatment. BSCM [Internet]. 2024 Apr. 19 [cited 2024 Dec. 23];54(3):151-6. Available from: https://he01.tci-thaijo.org/index.php/CMMJ-MedCMJ/article/view/87703

Issue

Section

Review Article